Carlos E. Espinoza

1.6k total citations · 1 hit paper
13 papers, 266 citations indexed

About

Carlos E. Espinoza is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carlos E. Espinoza has authored 13 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Carlos E. Espinoza's work include Pancreatic and Hepatic Oncology Research (4 papers), Phagocytosis and Immune Regulation (4 papers) and Immune cells in cancer (4 papers). Carlos E. Espinoza is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Phagocytosis and Immune Regulation (4 papers) and Immune cells in cancer (4 papers). Carlos E. Espinoza collaborates with scholars based in United States, Italy and Nigeria. Carlos E. Espinoza's co-authors include Marina Pasca di Magliano, Howard C. Crawford, Eileen S. Carpenter, Fatima Lima, Yaqing Zhang, Costas A. Lyssiotis, Katelyn L. Donahue, Zeribe C. Nwosu, Kristee Brown and Rosa E. Menjivar and has published in prestigious journals such as PLoS ONE, Cancer Research and eLife.

In The Last Decade

Carlos E. Espinoza

12 papers receiving 263 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arginase 1 is a key driver of immune suppression in pancreatic cancer

2023 96 citations Rosa E. Menjivar, Zeribe C. Nwosu et al. eLife profile →

Peers

Countries citing papers authored by Carlos E. Espinoza

Since Specialization

Citations

This map shows the geographic impact of Carlos E. Espinoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Espinoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Espinoza more than expected).

Fields of papers citing papers by Carlos E. Espinoza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos E. Espinoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Espinoza. The network helps show where Carlos E. Espinoza may publish in the future.

Co-authorship network of co-authors of Carlos E. Espinoza

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos E. Espinoza. A scholar is included among the top collaborators of Carlos E. Espinoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos E. Espinoza. Carlos E. Espinoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Fibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation 2025 ·Cancer Research ·(unknown), Carlos E. Espinoza, (unknown), (unknown), (unknown), Megan T. Hoffman, (unknown), (unknown), (unknown), Katelyn L. Donahue, (unknown), Padma Kadiyala, (unknown), Jiaqi Shi, Kyoung Eun Lee, Yaqing Zhang, Eileen S. Carpenter, (unknown), Timothy L. Frankel, Marina Pasca di Magliano	0
2	KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling 2025 ·JCI Insight ·(unknown), Ivana Barravecchia, (unknown), Jennifer M. Lee, (unknown), Carlos E. Espinoza, (unknown), (unknown), (unknown), (unknown), Kristee Brown, (unknown), Craig J. Galbán, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano, Stefanie Galbán	4
3	Malic enzyme 1 knockout has no deleterious phenotype and is favored in the male germline under standard laboratory conditions 2024 ·PLoS ONE ·(unknown), Mengrou Shan, Megan D. Radyk, (unknown), Christopher J. Halbrook, Lin Lin, Carlos E. Espinoza, (unknown), (unknown), (unknown), Marina Pasca di Magliano, Lewis C. Cantley, Jacob L. Mueller, Costas A. Lyssiotis	2
4	Arginase 1 is a key driver of immune suppression in pancreatic cancer breakdown → 2023 ·eLife ·Rosa E. Menjivar, Zeribe C. Nwosu, Wenting Du, Katelyn L. Donahue, Hanna S. Hong, Carlos E. Espinoza, Kristee Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima, (unknown), Padma Kadiyala, (unknown), Howard C. Crawford, Filip Bednar, Eileen S. Carpenter, Yaqing Zhang, Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano	96
5	Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence 2023 ·Molecular Cancer Therapeutics ·Monika Sharma, (unknown), (unknown), (unknown), (unknown), (unknown), Carlos E. Espinoza, Varunkumar Krishnamoorthy, Brian Magnuson, Mats Ljungman, Carl Koschmann, Joya Chandra, Christopher E. Whitehead, Judith S. Sebolt–Leopold, Stefanie Galbán	4
6	Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice 2023 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Brian Magnuson, (unknown), (unknown), Nina G. Steele, Carlos E. Espinoza, Craig J. Galbán, Nithya Ramnath, Timothy L. Frankel, Marina Pasca di Magliano, Stefanie Galbán	2
7	Abstract PR021: CCR1 expression defines pancreatic tumor associated macrophages and drives their immunosuppressive properties 2022 ·Cancer Research ·Yaqing Zhang, (unknown), Kristee Brown, (unknown), Zeribe C. Nwosu, Katelyn L. Donahue, Padma Kadiyala, (unknown), (unknown), (unknown), Carlos E. Espinoza, Marina Pasca di Magliano	1
8	Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1 2021 ·Cancer Research ·Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, Katelyn L. Donahue, Zeribe C. Nwosu, (unknown), Ashley Velez-Delgado, Rosa E. Menjivar, Fatima Lima, Stephanie The, Carlos E. Espinoza, Kristee Brown, Daniel D. Long, Costas A. Lyssiotis, Arvind Rao, Yaqing Zhang, Marina Pasca di Magliano, Howard C. Crawford	112
9	Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells 2020 ·Molecular Cancer Research ·Rachel K. Surowiec, (unknown), (unknown), Carlos E. Espinoza, Ranjit K. Mehta, (unknown), Veerin R. Sirihorachai, Karan Bedi, Mats Ljungman, Stefanie Galbán	22
10	Abstract 3855: Oncogenic Kras-mediated regulation of the tumor microenvironment in lung cancer 2020 ·Cancer Research ·Nina G. Steele, (unknown), (unknown), Jennifer M. Lee, Carlos E. Espinoza, Yaqing Zhang, Sundaresh Ram, Craig J. Galbán, Nithya Ramnath, Timothy L. Frankel, Marina Pasca di Magliano, Stefanie Galbán	2
11	Abstract A31: Investigating the effect of myeloid Arg1 deletion on tumor growth and CD8+ T-cell infiltration and activation in pancreatic cancer 2019 ·Cancer Research ·Rosa E. Menjivar, Christopher J. Halbrook, (unknown), Fatima Lima, Carlos E. Espinoza, Stefanie Galbán, Yaqing Zhang, Costas A. Lyssiotis, Marina Pasca di Magliano	2
12	A Bifunctional MAPK/PI3K Antagonist for Inhibition of Tumor Growth and Metastasis 2017 ·Molecular Cancer Therapeutics ·Stefanie Galbán, (unknown), Carlos E. Espinoza, Kevin Heist, Henry Haley, Karan Bedi, Mats Ljungman, Craig J. Galbán, Gary D. Luker, (unknown), Brian D. Ross	15
13	MRI-Guided Stereotactic Biopsy of Murine GBM for Spatiotemporal Molecular Genomic Assessment 2017 ·Tomography ·Stefanie Galbán, Wajd N. Al‐Holou, Hanxiao Wang, (unknown), Kevin Heist, Xin Hu, Roeland Verhaak, Yuan Zhu, Carlos E. Espinoza, Thomas L. Chenevert, (unknown), Craig J. Galbán, Brian D. Ross	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact